Vaxcyte Ownership | Who Owns Vaxcyte?


OverviewForecastFinancialsChartTranscripts

Vaxcyte Ownership Summary


Vaxcyte is owned by 30.08% institutional investors, 0.48% insiders, and 69.43% retail investors. Fmr is the largest institutional shareholder, holding 9.20% of PCVX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.10% of its assets in Vaxcyte shares.

PCVX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVaxcyte30.08%0.48%69.43%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr12.51M9.20%$450.61M
Vanguard group12.19M8.95%$562.63M
Ra capital management11.97M8.80%$431.01M
Janus henderson group10.58M8.55%$865.61M
Blackrock9.94M8.48%$750.56M
Blackrock funding, inc. /de10.25M7.52%$472.77M
T. rowe price investment management8.32M6.11%$299.52M
Wellington management group llp5.03M3.70%$181.28M
State street4.79M3.52%$172.39M
Paradigm biocapital advisors lp3.78M2.78%$136.33M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pivotal bioventure partners investment advisor1.37M28.58%$49.43M
Kynam capital management, lp3.07M8.24%$110.64M
Saturn v capital management788.44K6.23%$28.40M
Ra capital management11.97M5.31%$431.01M
Paradigm biocapital advisors lp3.78M3.88%$136.33M
Ghost tree capital150.00K3.55%$11.33M
Eversept partners, lp1.42M3.53%$51.22M
Deep track capital, lp3.00M3.02%$108.06M
Novo916.16K2.13%$33.00M
Logos global management lp625.00K2.02%$22.51M

Top Buyers

HolderShares% AssetsChange
T. rowe price investment management8.32M0.18%2.31M
Norges bank1.23M0.01%1.23M
Deep track capital, lp3.00M3.02%850.00K
Point72 asset management696.84K0.04%696.84K
Logos global management lp625.00K2.02%625.00K

Top Sellers

HolderShares% AssetsChange
Darwin global management---2.20M
Commodore capital lp---1.65M
Price t rowe associates inc /md/1.69M0.01%-1.48M
Avoro capital advisors---1.00M
Hood river capital management---751.61K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.23M0.01%1.23M$56.70M
Logos global management lp625.00K2.02%625.00K$22.51M
Soleus capital management608.96K1.04%608.96K$28.10M
Adage capital partners gp333.00K0.02%333.00K$11.99M
Balyasny asset management104.84K0.01%104.84K$3.41M

Sold Out

HolderChange
Jfs wealth advisors-1.00
Dinuzzo private wealth-1.00
Global financial private client-1.00
Mai capital management-2.00
Capital performance advisors llp-3.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025136-53.58%40,972,706-71.00%300.28%69-52.08%44-55.56%
Sep 30, 2025123-58.16%39,571,115-72.00%290.27%52-71.58%52-29.73%
Jun 30, 2025302-7.93%147,482,0231.73%1080.95%183-2.66%77-20.62%
Mar 31, 202535-89.64%28,246,930-79.94%200.16%20-90.10%6-93.02%
Dec 31, 2024130-62.54%38,665,990-71.44%310.26%83-61.03%32-63.64%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.47M3.10%366.37K
Vanguard US Total Market Shares ETF3.67M2.85%587.74K
Vanguard Health Care Inv3.28M2.28%449.12K
Vanguard Small Cap Index3.21M2.23%249.70K
iShares Russell 2000 ETF2.99M2.08%1.86M
Janus Inst Mid Cap Growth CF2.57M1.79%-
Janus Henderson Enterprise D2.57M1.79%-
Janus Concentrated Growth CF2.16M1.67%-
Janus Henderson Forty S2.16M1.66%-
State Street® SPDR® S&P® Biotech ETF2.31M1.60%-12.35K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 11, 2026Cowan Elvia SVP, Finance & CAOSell$146.48K
Mar 10, 2026Wassil Jim CHIEF OPERATING OFFICERSell$141.53K
Mar 10, 2026Wassil Jim CHIEF OPERATING OFFICERSell$293.91K
Dec 31, 2025Dhaliwal Harpreet S. Chief Technical Ops OfficerSell$454.89K
Dec 23, 2025Cowan Elvia SVP, FINANCESell$321.93K

Insider Transactions Trends


DateBuySell
2026 Q1-3
2025 Q4-3
2025 Q3--
2025 Q2--
2025 Q1-32

PCVX Ownership FAQ


Who Owns Vaxcyte?

Vaxcyte shareholders are primarily institutional investors at 30.08%, followed by 0.48% insiders and 69.44% retail investors. The average institutional ownership in Vaxcyte's industry, Biotech Stocks , is 381.47%, which Vaxcyte falls below.

Who owns the most shares of Vaxcyte?

Vaxcyte’s largest shareholders are Fmr (12.51M shares, 9.20%), Vanguard group (12.19M shares, 8.95%), and Ra capital management (11.97M shares, 8.80%). Together, they hold 26.95% of Vaxcyte’s total shares outstanding.

Does Blackrock own Vaxcyte?

Yes, BlackRock owns 8.48% of Vaxcyte, totaling 9.94M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 750.56M$. In the last quarter, BlackRock increased its holdings by 426.84K shares, a 4.49% change.

Who is Vaxcyte’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Vaxcyte’s biggest shareholder by percentage of total assets invested, with 28.58% of its assets in 1.37M Vaxcyte shares, valued at 49.43M$.

Who is the top mutual fund holder of Vaxcyte shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Vaxcyte shares, with 3.10% of its total shares outstanding invested in 4.47M Vaxcyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools